The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Neurotransmitters as food supplements: the effects of GABA on brain and behavior
Open accessAbstract
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the human cortex. The food supplement version of GABA is widely available online. Although many consumers claim that they experience benefits from the use of these products, it is unclear whether these supplements confer benefits beyond a placebo effect. Currently, the mechanism of action behind these products is unknown. It has long been thought that GABA is unable to cross the blood-brain barrier (BBB), but the studies that have assessed this issue are often contradictory and range widely in their employed methods. Accordingly, future research needs to establish the effects of oral GABA administration on GABA levels in the human brain, for example using magnetic resonance spectroscopy. There is some evidence in favor of a calming effect of GABA food supplements, but most of this evidence was reported by researchers with a potential conflict of interest. We suggest that any veridical effects of GABA food supplements on brain and cognition might be exerted through BBB passage or, more indirectly, via an effect on the enteric nervous system. We conclude that the mechanism of action of GABA food supplements is far from clear, and that further work is needed to establish the behavioral effects of GABA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Steenbergen, L., Sellaro, R., Stock, A., Verkuil, B., Beste, C., & Colzato, L. S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.015 · Cited by 125
Self-citationRetractedSteenbergen, L., Sellaro, R., Stock, A., Beste, C., & Colzato, L. S. (2015) · Scientific Reports · doi:10.1038/srep12770 · Cited by 35
Self-citationRetractedMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M. W., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,471
Response inhibition in the stop-signal paradigm
Verbruggen, F., & Logan, G. D. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2008.07.005 · Cited by 1,373
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Cited by
The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling
Mazzoli, R., & Pessione, E. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01934 · Cited by 383
The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective
Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.04.002 · Cited by 326
“Whether the peripherally derived GABA is capable of crossing the BBB either through diffusion or through active transport remains a matter of dispute (Boonstra et al., 2015).”
BackgroundOlive Polyphenols: Antioxidant and Anti-Inflammatory Properties
Bucciantini, M., Leri, M., Nardiello, P., Casamenti, F., & Stefani, M. (2021) · Antioxidants · doi:10.3390/antiox10071044 · Cited by 301
Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 295
Hepsomali, P., Groeger, J. A., Nishihira, J., & Scholey, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00923 · Cited by 281
Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions
Coelho, M. C., Malcata, F. X., & Silva, C. C. G. (2022) · Foods · doi:10.3390/foods11152276 · Cited by 276
Diez-Gutiérrez, L., San Vicente, L., R. Barrón, L. J., Villarán, M. D. C., & Chávarri, M. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103669 · Cited by 255
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208
United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA)
Oketch-Rabah, H. A., Madden, E. F., Roe, A. L., & Betz, J. M. (2021) · Nutrients · doi:10.3390/nu13082742 · Cited by 140
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
Savage, K., Firth, J., Stough, C., & Sarris, J. (2018) · Phytotherapy Research · doi:10.1002/ptr.5940 · Cited by 131
Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis
Iriondo-DeHond, A., Uranga, J. A., del Castillo, M. D., & Abalo, R. (2020) · Nutrients · doi:10.3390/nu13010088 · Cited by 126
van de Wouw, M., Walsh, A. M., Crispie, F., van Leuven, L., Lyte, J. M., Boehme, M., Clarke, G., Dinan, T. G., Cotter, P. D., & Cryan, J. F. (2020) · Microbiome · doi:10.1186/s40168-020-00846-5 · Cited by 123
de Wouw, M. V., Walsh, A. M., Crispie, F., Leuven, L. V., Lyte, J. M., Boehme, M., Clarke, G., Dinan, T. G., Cotter, P. D., & Cryan, J. (2020) · doi:10.21203/rs.2.19926/v1 · Cited by 123
Microbial composition of Kombucha determined using amplicon sequencing and shotgun metagenomics
Arıkan, M., Mitchell, A. L., Finn, R. D., & Gürel, F. (2020) · Journal of Food Science · doi:10.1111/1750-3841.14992 · Cited by 123
Brain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
Gut–Brain Axis in Regulation of Blood Pressure
Yang, T., & Zubcevic, J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00845 · Cited by 74
“…have been shown to be abundant in the intestine (Reeds et al., 2000; Hyland and Cryan, 2010), and the GI tract harbors abundant gram-positive facultative anaerobic bacteria Lactobacillus and Bifidobacterium, both of which are able tometabolize glutamate to produce GABA (Boonstra et al., 2015).”
BackgroundInfluentialBacterially produced metabolites protect C. elegans neurons from degeneration
Urrutia, A., García-Angulo, V. A., Fuentes, A., Caneo, M., Legüe, M., Urquiza, S., Delgado, S. E., Ugalde, J., Burdisso, P., & Calixto, A. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000638 · Cited by 71
Salami, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.613120 · Cited by 67
Lopes Sakamoto, F., Metzker Pereira Ribeiro, R., Amador Bueno, A., & Oliveira Santos, H. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104395 · Cited by 49
Tyagi, P., Tasleem, M., Prakash, S., & Chouhan, G. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109489 · Cited by 42
Hannant, P., Cassidy, S., Renshaw, D., & Joyce, A. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1588486 · Cited by 16
Metadata
- Authors
- Boonstra, E., de Kleijn, R., Colzato, L. S., Alkemade, A., Forstmann, B. U., & Nieuwenhuis, S.
- Venue
- Frontiers in Psychology
- Publisher
- Frontiers Media SA
- Published
- 2015-10-06
- Volume
- 6
- Pages
- 1520-1520
- ISSN
- 1664-1078 (ISSN-L)
- OpenAlex
- W2109086173
- Cited by
- 329
- References
- 50
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.